How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...
05 Jun, 2026, 05.36 PM IST
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
03 Jun, 2026, 02.36 PM IST
Weather swings, monsoon risks, and the growing threat to mango, apple cropsThe agriculture industry has evolved historically through adaptation and resilience, and now it is time to speed up this transformation, em...
01 Jun, 2026, 11.43 AM IST
What if chronic nerve pain isn’t just something to block, but something to fix at the cellular level? New study reveals potential way to “recharge” nerve cells to relieve long-term painScientists are exploring a new way to treat chronic nerve pain by focusing on mitochondria, the energy-producing parts of cells. Researcher...
30 May, 2026, 05.48 AM IST
Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
20 May, 2026, 02.53 PM IST
HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
20 May, 2026, 12.18 PM IST
Global Market: Hong Kong IPO boom draws rising interest from overseas companiesHong Kong's stock market is seeing more foreign companies file for listings. Firms from countries like Indonesia and South Korea are explor...
20 May, 2026, 09.58 AM IST
Open to 4-5 acquisitions, but at sensible valuations: Ameera Shah, promoter and executive chairperson, Metropolis HealthcareMetropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic ac...
15 May, 2026, 12.41 AM IST
Zydus to buy Assertio for $166.4 millionZydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...
14 May, 2026, 11.15 AM IST
Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...
14 May, 2026, 01.22 AM IST
Quote of the day by American psychologist Carl Rogers: 'When someone really hears you without passing judgment...' Life lessons from world-famous psychologist about empathy, human connection & emotional safetyQuote of the day by American psychologist Carl Rogers: Carl Rogers believed that one of the most powerful human experiences is simply being...
12 May, 2026, 08.23 PM IST
Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
08 May, 2026, 10.19 PM IST
Academy of Digital Health Sciences launches ‘AI for All’ healthcare initiativeTwo new educational programs are being introduced to support this goal. These programs are designed to equip professionals with the skills ...
07 May, 2026, 01.22 PM IST
ISIS-linked women and children set to arrive in Australia; Federal Police reveal plan, including arrests, for ISIS-bride cohortAustralian authorities are preparing for the arrival of ISIS-linked women and children. The Australian Federal Police has a plan for monito...
06 May, 2026, 02.24 PM IST
Kiran Mazumdar-Shaw picks niece Claire as successor at BioconBiocon's founder Kiran Mazumdar-Shaw has made a groundbreaking announcement, pledging her niece Claire Mazumdar as her heir apparent. The t...
06 May, 2026, 01.07 AM IST
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
05 May, 2026, 05.35 PM IST
Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
05 May, 2026, 11.51 AM IST